Description
Developing an innovative strategy for hypertension detection, treatment and control in two middle income countries (Hypertension Outcomes Prevention and Evaluation: HOPE-4)
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02012-03-01$1,486,821
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2012-03-01(start date) | $1,486,821 | — | Developing an innovative strategy for hypertension detection, treatment and control in two middle income count… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2013-2014-Q2-00598 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $250,000 | FY2014 |
| 236-2012-2013-Q2-00569 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $1,118,239 | FY2013 |
| 236-2012-2013-Q1-00040 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $75,000 | FY2013 |
| 236-2011-2012-Q1-00306 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $583,378 | FY2012 |
| 236-2011-2012-Q2-00250 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $42,000 | FY2011 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2011-2012-Q4-00211 · retrieved 2026-11-14.